Four-fifths of pharmacists are facing “overwhelming” workplace pressures, a survey of the profession indicates.
This module will help you to understand and educate customers about the risks of antibiotic resistance, and recommend products to help them effectively manage their sore throat symptoms.
More than a fifth of pharmacists on the GPhC register who responded to a study said they are dissatisfied in their role.
The study of 2,000 people found that 66 per cent are worried they will catch a sore throat or cough while using public transport.
An export ban on colestyramine sachets and fluticasone propionate nasules came into effect on December 5.
Local approaches to PCNs should be co-ordinated, says North East London LPC chief officer Hemant Patel.
The team behind an online job booking platform for locum healthcare professionals have secured £1m in equity funding.
Some contractors are “losing tens of thousands of pounds” due to errors made when submitting EPS claims.
Dr Richard Torbett takes over as ABPI chief exec in Jnuary 2020.
Scottish Government continues with £800 funding for pharmacy staff training.
Numbers in contact with drug and alcohol services between April 2018 and March 2019 remains flat at around 268,000.
MHRA looking at reclassification of HRT and OCs to Pharmacy medicines.
If you've got a website, you need to keep it healthy, say digital strategists Salience
Farah Ali of Warman-Freed, Perrigo's learning pharmacy, shares her immediate thoughts and actions as the five-year deal is announced
The GPhC has approved new guidance for pharmacist prescribers.
Head of Alphega Pharmacy UK Raj Nutan reflects on the trends at this year's Pharmacy Show
Artificial intelligence and wearable technology are set to revolutionise the healthcare market in the next few years.
Pharmacy can do better than some of the tactics being employed in the general election
PSNC chief Simon Dukes reminds pharmacists unhappy with the five-year deal not to forget about annual reviews.
Researchers say the NMS will save the NHS in England £651m and give patients almost 300,000 ‘quality adjusted life years’.